Registered Kenya · PPB

DOC 100

DOXYCYLINE 100MG

H2012/CTD432/383 100MG GENERIC/BIOSIMILARS

What it does

Doxycycline is an antibiotic used to treat various infections.

Commonly used for: bacterial infections, acne, chlamydia, malaria prevention …

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2012/CTD432/383
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
DOXYCYLINE 100MG
Dosage form
100MG
Strength
-
Pack size
100'S
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Knvm Medicare
Country of origin
FOREIGN
Manufacturer location
Level- 7, 8, 13, 14 [Lift] Nasir Trade Centre 89, Old Sonargaon Road, ঢাকা 1205, Bangladesh

Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:36:53 · updated 2026-08-03 02:23:46

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Doxycycline is an antibiotic used to treat various infections.

What it treats

  • bacterial infections
  • acne
  • chlamydia
  • malaria prevention
  • periodontal disease

How it works

It works by stopping the growth of bacteria and preventing them from multiplying.

Who it's for

Doxycycline is for adults and children over the age of 8 who need treatment for bacterial infections.

Cautions

  • • Not suitable for pregnant women or breastfeeding mothers.
  • • May cause sensitivity to sunlight; use sun protection.
  • • Can affect bone and teeth development in young children.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: doxycyline

BNF-referenced

Doxycycline is a broad-spectrum tetracycline antibiotic, derived from oxytetracycline. It is effective against a variety of gram-positive and gram-negative bacteria, as well as some protozoa. Doxycycline is commonly used for the treatment of infections such as respiratory tract infections, urinary tract infections, and acne. It is also employed for prophylaxis in certain conditions, such as malaria.

Indications

  • Bacterial infections
  • Respiratory tract infections
  • Urinary tract infections
  • Acne
  • Malaria prophylaxis
  • Periodontal disease

Dosage

Children: For children aged 8 years and older, the usual dose for most infections is 2 mg/kg body weight as a loading dose on the first day, followed by 1 mg/kg daily. For children under 8 years, doxycycline is generally not recommended.

Adults: The usual adult dose for most infections is 100 mg to 200 mg daily, administered in one or two divided doses.

Mechanism of action

Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. This binding prevents the attachment of aminoacyl-tRNA to the acceptor site on the mRNA-ribosome complex, thereby inhibiting the elongation of the peptide chain and ultimately leading to bacteriostatic effects.

Pharmacodynamics

Doxycycline exhibits a time-dependent killing effect, with its efficacy being related to the duration of exposure above the minimum inhibitory concentration (MIC). It has a longer half-life compared to other tetracyclines, allowing for once or twice daily dosing. It also possesses anti-inflammatory properties, which can contribute to its effectiveness in treating acne and other inflammatory conditions.

Pharmacokinetics

Doxycycline is well absorbed from the gastrointestinal tract, with an oral bioavailability of approximately 90%. It is widely distributed throughout body tissues and fluids, including the central nervous system. The drug is primarily excreted in the bile and undergoes enterohepatic recirculation, with minimal renal excretion. Its half-life is approximately 18-22 hours, allowing for convenient dosing schedules.

Contra-indications

  • Hypersensitivity to doxycycline or any of the tetracycline antibiotics.
  • Severe renal impairment (creatinine clearance < 50 mL/min).
  • Pregnancy, particularly during the second and third trimesters.

Adverse effects

  • Gastrointestinal disturbances (nausea, vomiting, diarrhea).
  • Photosensitivity reactions.
  • Esophageal irritation or ulceration.
  • Skin rashes.
  • Alterations in liver function tests.
  • Intracranial hypertension.

Interactions

  • Antacids containing aluminum, calcium, or magnesium can reduce the absorption of doxycycline.
  • Iron preparations may also interfere with absorption.
  • Oral contraceptives may be less effective when used concurrently with doxycycline.
  • Warfarin and other anticoagulants may have increased effects.

Precautions

  • Use with caution in patients with a history of esophageal disorders.
  • Monitor liver function in patients with pre-existing liver disease.
  • Caution in renal impairment, as dosage adjustments may be necessary.
  • Avoid use in children under 12 years of age due to potential effects on bone growth and teeth.

Pregnancy

Doxycycline is contraindicated in pregnancy, especially during the second and third trimesters due to the risk of harm to the developing fetus, including effects on bone and teeth.

Breast-feeding

Doxycycline is excreted in breast milk. Caution is advised when administering to nursing mothers, as it may affect the infant's teeth and bone development.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Capsules
  • Tablets
  • Oral suspension
  • Injectable solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: doxycyline

PubChem CID 54713166

Molecular formula: C22H24N2O8

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.